{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:15:06Z","timestamp":1769804106244,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Project of China","award":["2021YFC2501302"],"award-info":[{"award-number":["2021YFC2501302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07830-0","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:48:55Z","timestamp":1764445735000},"page":"1189-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A prospective study to compare the efficacy and safety of glucocorticoid-free maintenance therapy versus low-dose glucocorticoid maintenance therapy for lupus nephritis\u2014a pilot, single-center, randomized controlled study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8438-2287","authenticated-orcid":false,"given":"Yingxin","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-4504","authenticated-orcid":false,"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"7830_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225826","author":"Y Fei","year":"2024","unstructured":"Fei Y, Zhao L, Wu L et al (2024) Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2024-225826","journal-title":"Ann Rheum Dis"},{"key":"7830_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae294","author":"G Figueroa-Parra","year":"2024","unstructured":"Figueroa-Parra G, Bautista-Vargas M, Navarro-Mendoza E et al (2024) Optimal glucocorticoid therapy in lupus nephritis. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfae294","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"7830_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40265-025-02156-2","volume":"85","author":"Y Tanaka","year":"2025","unstructured":"Tanaka Y (2025) Revolutionary changes in the management of lupus nephritis: towards de-glucocorticoid or no-glucocorticoid. Drugs 85(4):447\u2013455. https:\/\/doi.org\/10.1007\/s40265-025-02156-2","journal-title":"Drugs"},{"key":"7830_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.622225","volume":"8","author":"JM Mej\u00eda-Vilet","year":"2021","unstructured":"Mej\u00eda-Vilet JM, Ayoub I (2021) The use of glucocorticoids in lupus nephritis: new pathways for an old drug. Front Med 8:622225. https:\/\/doi.org\/10.3389\/fmed.2021.622225","journal-title":"Front Med"},{"issue":"9","key":"7830_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725\u20131725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"issue":"12","key":"7830_CR6","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1681\/asn.2017030263","volume":"28","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liu Z, Zhou M, Chen J, Xing C, Lin H, Ni Z, Fu P, Liu F, Chen N, He Y, Liu J, Zeng C (2017) Multitarget therapy for maintenance treatment of lupus nephritis. J Am Soc Nephrol 28(12):3671\u20133678. https:\/\/doi.org\/10.1681\/asn.2017030263","journal-title":"J Am Soc Nephrol"},{"key":"7830_CR7","doi-asserted-by":"publisher","unstructured":"Mathian A, Pha M, Haroche J et al (2020) Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216303","DOI":"10.1136\/annrheumdis-2019-216303"},{"issue":"1","key":"7830_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000173","volume":"4","author":"P Ngamjanyaporn","year":"2017","unstructured":"Ngamjanyaporn P, McCarthy EM, Sergeant JC, Reynolds J, Skeoch S, Parker B, Bruce IN (2017) Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey. Lupus Sci Med 4(1):e000173. https:\/\/doi.org\/10.1136\/lupus-2016-000173","journal-title":"Lupus Sci Med"},{"issue":"7","key":"7830_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/0961203313490434","volume":"22","author":"ZA Zahr","year":"2013","unstructured":"Zahr ZA, Fang H, Magder LS, Petri M (2013) Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort. Lupus 22(7):697\u2013701. https:\/\/doi.org\/10.1177\/0961203313490434","journal-title":"Lupus"},{"issue":"12","key":"7830_CR10","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1093\/rheumatology\/keab149","volume":"60","author":"L Ji","year":"2021","unstructured":"Ji L, Xie W, Zhang Z (2021) Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual. Rheumatology (Oxford) 60(12):5517\u20135526. https:\/\/doi.org\/10.1093\/rheumatology\/keab149","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7830_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10067-018-4377-7","volume":"38","author":"RP Goswami","year":"2019","unstructured":"Goswami RP, Sit H, Ghosh P, Sircar G, Ghosh A (2019) Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre. Clin Rheumatol 38(4):1089\u20131097. https:\/\/doi.org\/10.1007\/s10067-018-4377-7","journal-title":"Clin Rheumatol"},{"key":"7830_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000603","author":"L Ji","year":"2022","unstructured":"Ji L, Xie W, Fasano S et al (2022) Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2021-000603","journal-title":"Lupus Sci Med"},{"issue":"2","key":"7830_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000916","volume":"5","author":"C Tani","year":"2019","unstructured":"Tani C, Elefante E, Signorini V, Zucchi D, Lorenzoni V, Carli L, Stagnaro C, Ferro F, Mosca M (2019) Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience. RMD Open 5(2):e000916. https:\/\/doi.org\/10.1136\/rmdopen-2019-000916","journal-title":"RMD Open"},{"key":"7830_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40697-014-0030-9","volume":"1","author":"L Galbraith","year":"2014","unstructured":"Galbraith L, Manns B, Hemmelgarn B et al (2014) The steroids in the maintenance of remission of proliferative lupus nephritis (SIMPL) pilot trial. Can J Kidney Health Dis 1:30. https:\/\/doi.org\/10.1186\/s40697-014-0030-9","journal-title":"Can J Kidney Health Dis"},{"issue":"1","key":"7830_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000157","volume":"3","author":"D Apostolopoulos","year":"2016","unstructured":"Apostolopoulos D, Kandane-Rathnayake R, Raghunath S, Hoi A, Nikpour M, Morand EF (2016) Independent association of glucocorticoids with damage accrual in SLE. Lupus Sci Med 3(1):e000157. https:\/\/doi.org\/10.1136\/lupus-2016-000157","journal-title":"Lupus Sci Med"},{"issue":"3","key":"7830_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3899\/jrheum.080828","volume":"36","author":"M Thamer","year":"2009","unstructured":"Thamer M, Hern\u00e1n MA, Zhang Y, Thamer MAE, Zhang YI, Cotter DENNIS, Petri MICHELLE (2009) Prednisone, lupus activity, and permanent organ damage. J Rheumatol 36(3):560\u2013564. https:\/\/doi.org\/10.3899\/jrheum.080828","journal-title":"J Rheumatol"},{"issue":"1","key":"7830_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrneph.2014.215","volume":"11","author":"TM Chan","year":"2015","unstructured":"Chan TM (2015) Treatment of severe lupus nephritis: the new horizon. Nat Rev Nephrol 11(1):46\u201361. https:\/\/doi.org\/10.1038\/nrneph.2014.215","journal-title":"Nat Rev Nephrol"},{"key":"7830_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109166","volume":"245","author":"J Zheng","year":"2022","unstructured":"Zheng J, Zhu L, Ju B, Zhang J, Luo J, Wang Y, Lv XiaoHong, Pu D, He L, Wang J (2022) Peripheral immunophenotypes associated with the flare in the systemic lupus erythematosus patients with low disease activity state. Clin Immunol 245:109166. https:\/\/doi.org\/10.1016\/j.clim.2022.109166","journal-title":"Clin Immunol"},{"issue":"10","key":"7830_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11926-023-01109-6","volume":"25","author":"A Banos","year":"2023","unstructured":"Banos A, Bertsias G (2023) Flares in lupus nephritis: risk factors and strategies for their prevention. Curr Rheumatol Rep 25(10):183\u2013191. https:\/\/doi.org\/10.1007\/s11926-023-01109-6","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"7830_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101865","volume":"37","author":"A Askanase","year":"2023","unstructured":"Askanase A, Khalili L, Tang W, Mertz P, Scherlinger M, Sebbag E, Chasset F, Felten R, Arnaud L (2023) New and future therapies: changes in the therapeutic armamentarium for SLE. Best Pract Res Clin Rheumatol 37(4):101865. https:\/\/doi.org\/10.1016\/j.berh.2023.101865","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"7830_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082211","volume":"13","author":"F Alenzi","year":"2024","unstructured":"Alenzi F, Ateka-Barrutia O, Ken Cheah C, Khamashta M, Sangle SR, D\u2019Cruz DP (2024) Lupus nephritis outcomes after stopping immunosuppression. J Clin Med 13(8):8. https:\/\/doi.org\/10.3390\/jcm13082211","journal-title":"J Clin Med"},{"key":"7830_CR22","doi-asserted-by":"publisher","unstructured":"Gatto M, Frontini G, Calatroni M et al (2024) Effect of sustained clinical remission on the risk of lupus flares and impaired kidney function in patients with lupus nephritis. Kidney Int Rep. https:\/\/doi.org\/10.1016\/j.ekir.2024.01.016","DOI":"10.1016\/j.ekir.2024.01.016"},{"issue":"11","key":"7830_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/0961203310371154","volume":"19","author":"DJ Birmingham","year":"2010","unstructured":"Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19(11):1272\u20131280. https:\/\/doi.org\/10.1177\/0961203310371154","journal-title":"Lupus"},{"key":"7830_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694928","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Liu M (2021) Complement C4, infections, and autoimmune diseases. Front Immunol 12:694928. https:\/\/doi.org\/10.3389\/fimmu.2021.694928","journal-title":"Front Immunol"},{"issue":"1","key":"7830_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000452104","volume":"26","author":"AJ Madu","year":"2017","unstructured":"Madu AJ, Ughasoro MD (2017) Anaemia of chronic disease: an in-depth review. Med Princ Pract 26(1):1\u20139. https:\/\/doi.org\/10.1159\/000452104","journal-title":"Med Princ Pract"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07830-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:50Z","timestamp":1769763770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7830"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07830-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was both conducted in accordance with principles of the Declaration of Helsinki, the International Conference on Harmonization Guidelines for Good Clinical Practice, and applicable regulations of all countries with participating study sites. Study protocols were reviewed and approved by Independent ethics committee of Jinling Hospital (2020NZKY-023). All patients provided written informed consent prior to participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}